Common Contracts
10 similar Unit Purchase Agreement contracts by BioSig Technologies, Inc., Relmada Therapeutics, Inc., Guerrilla RF, Inc., others
UNIT PURCHASE AGREEMENT BY AND AMONG GUERRILLA RF, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETOUnit Purchase Agreement • January 3rd, 2023 • Guerrilla RF, Inc. • Semiconductors & related devices • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of December 30, 2022 by and among Guerrilla RF, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
FORM OF UNIT PURCHASE AGREEMENT BY AND AMONG SUMMIT WIRELESS TECHNOLOGIES, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETO EXHIBITS TO UNIT PURCHASE AGREEMENTUnit Purchase Agreement • March 3rd, 2020 • Summit Wireless Technologies, Inc. • Semiconductors & related devices • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of February 4, 2020 by and among Summit Wireless Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
AMENDED AND RESTATED UNIT PURCHASE AGREEMENT BY AND AMONG RELMADA THERAPEUTICS, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETOUnit Purchase Agreement • December 3rd, 2019 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
This AMENDED AND RESTATED UNIT PURCHASE AGREEMENT (this “Agreement”) entered into as of November 27, 2019, and effective as of February 12, 2019, by and among Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”) amends and restates in its entirety the Unit Purchase Agreement among the parties hereto dated as of February 12, 2019.
UNIT PURCHASE AGREEMENT BY AND AMONG HOTH THERAPEUTICS, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETO DISCLOSURE SCHEDULES AND EXHIBITS TO UNIT PURCHASE AGREEMENTUnit Purchase Agreement • August 21st, 2019 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of ____, 2019 by and among Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
UNIT PURCHASE AGREEMENT BY AND AMONG RELMADA THERAPEUTICS, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETO DISCLOSURE SCHEDULES AND EXHIBITS TO UNIT PURCHASE AGREEMENTUnit Purchase Agreement • May 15th, 2019 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of March ____, 2019 by and among Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
UNIT PURCHASE AGREEMENT BY AND AMONG RELMADA THERAPEUTICS, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETO DISCLOSURE SCHEDULES AND EXHIBITS TO UNIT PURCHASE AGREEMENTUnit Purchase Agreement • November 13th, 2018 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of ____, 2018 by and among Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
UNIT PURCHASE AGREEMENT BY AND AMONGUnit Purchase Agreement • May 1st, 2018 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of [●], 2018 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
UNIT PURCHASE AGREEMENT BY AND AMONGUnit Purchase Agreement • August 3rd, 2017 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of April 6, 2017 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
UNIT PURCHASE AGREEMENT BY AND AMONG BIOSIG TECHNOLOGIES, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETOUnit Purchase Agreement • October 29th, 2015 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of October 23, 2015 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMPOSITE UNIT PURCHASE AGREEMENT BY AND AMONG BIOSIG TECHNOLOGIES, INC. AND EACH PURCHASER IDENTIFIED ON THE SIGNATURE PAGES HERETOUnit Purchase Agreement • February 20th, 2015 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of December 19, 2014 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
